Specific targeting of STAT3 expression in cervical cancer cell lines have been performed earlier using recombinant adenoviral dominant negative STAT3 [21] or STAT3 specific siRNA [22] which invariably demonstrated similar decrease in cell numbers and affected the viability of cervical cancer cells. The gene discussed is STAT3; the disease is cervical carcinoma.